Genomics in cancer care market is driven with increased R and D activities and investments in pharma industry, North America is dominating genomics in cancer care market due to developing biotech industry
Halfway into 2016, this seems the right time to assess the trends seen in the industry. What is being seen midway into the year is not a bad milestone to judge where the rest of the year is likely to head.
We accept all press releases with good faith and trust that contributors submit items with the best of intentions. However, if you dispute the contents of any item then please contact us and we will remove it until a full inquiry has taken place.